ArticleClinical, cosmetic and investigational dermatology2026
A Double-Blinded, Split-Face Clinical Trial Evaluating the Effects of a Vitamin C, E, and Ferulic Acid Serum Combined with Microneedling on Facial Photoaging.
Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Microneedling achieves skin rejuvenation through controlled microinjury, while topical antioxidants may enhance its outcomes by neutralizing reactive oxygen species and promoting tissue repair. This study evaluated whether a topical antioxidant formulation containing vitamins C, E, and ferric acid enhances facial rejuvenation outcomes when combined with microneedling. Patients and Methods: A 12-week, prospective, randomized, double-blinded, split-face trial was conducted in 31 adults with signs of facial aging. After subjects receiving microneedling treatments on both sides of the face, one side was randomly assigned to receive application of antioxidant serum while the other receiving placebo serum. Microneedling was performed at baseline and Week 4. Clinical efficacy throughout 12 weeks at four-week interval was assessed using the modified Griffith's scale, hemi-MASI, Global Aesthetic Improvement Scale (GAIS), and non-invasive skin biophysical measurements. Results: At Week 12, the Microneedle + Antioxidant side demonstrated significantly greater improvements in modified Griffith's scale scores (23.9% vs 6.8%, p<0.001), hemi-MASI scores (31.2% vs 5.1%, p<0.001), and skin elasticity (39.0% vs 6.8%, p<0.001) compared to Microneedle + Placebo. GAIS assessment revealed 89.3% of antioxidant-treated sides achieved marked/near-total improvement versus 7.1% of placebo-treated sides. The antioxidant-treated sides also demonstrated superior improvements in skin elasticity (39.0% vs 6.8%, p<0.001) and melanin index (21.3% vs 3.4%, p<0.001). Only mild, transient side effects were reported. Conclusion: Combining topical antioxidant serum with microneedling provides superior outcomes for facial rejuvenation than microneedling alone. This combination protocol significantly improves clinical signs of photoaging, including skin elasticity, rhytides, and dyspigmentation, suggesting an optimized treatment protocol with minimal recovery time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.